酸化ストレスアッセイの世界市場（2024年～2031年）

酸化ストレスアッセイの世界市場は、予測期間（2024年～2031年）にCAGR8.3％で成長すると予測されます。酸化ストレスアッセイの世界市場は、慢性疾患の増加、高齢化、環境要因、個別化医療へのシフトなど、さまざまな要因の影響を受けています。がん、心血管疾患、糖尿病、神経変性疾患などの慢性疾患は、抗酸化防御機構の低下により酸化ストレスを受けやすくなります。高齢化社会では、汚染物質や毒素にさらされる機会が増えるため、さらに酸化ストレスを受けやすくなります。個別化医療へのシフトがバイオマーカーベースのアッセイに対する需要を煽り、ヘルスケアプロバイダーが個々の患者の特性に基づいて治療戦略を調整することを可能にしています。技術の進歩により、酸化ストレス測定の感度、特異性、精度が向上しています。FDAやEMAなどの規制当局からの支援は、ヘルスケア現場での採用を後押ししています。啓発キャンペーンや学術機関、研究機関、バイオテクノロジー企業間の連携が、市場の成長をさらに後押ししています。

市場力学

酸化ストレスに対する感受性の増大

加齢により抗酸化防御機能が低下し、酸化ストレスに関連した症状が増加します。高齢化人口の増加に伴い、早期発見とモニタリングのために酸化ストレスアッセイの需要が増加しています。米国疾病予防管理センター（.gov）によると、 2022年9月現在、米国の高齢化は前例のないレベルに達しており、2019年には65歳以上の成人が5,410万人に達し、人口の16.0％を占めています。2040年までにこの数は8,080万人に増加し、2060年までに9,470万人に達し、総人口のほぼ25.0％を占めると予測されています。 加齢に伴い、認知症、心臓病、2型糖尿病、関節炎、がんなどの慢性疾患のリスクも高まり、多額の医療費と社会的影響をもたらします。

公衆衛生への取り組みと政府政策の高まり

政府や国際機関は、慢性疾患に対処し、ヘルスケア・インフラを改善するために、公衆衛生イニシアチブに投資しています。酸化ストレスアッセイを国家保健プログラムに組み込むことは、エビデンスに基づく政策立案を支援し、市場の成長を刺激します。世界保健機関（WHO）によると、2023年12月に世界の保健支出は過去最高の9兆8,000億米ドルに達し、GDPの10.3%を占めました。しかし、支出の分配は依然として不平等で、政府支出が減少した低所得国を除き、公的支出は世界的に増加しています。低所得国が世界の医療費に占める割合はわずか0.24％でした。

市場セグメンテーション

当レポートでは、酸化ストレスアッセイの世界市場を製品タイプ、検査タイプ、技術、疾患タイプ、エンドユーザー別に詳細に分析しています：

• 製品別では、市場は機器、消耗品、サービスに細分化されます。
• 検査タイプ別では、市場は間接アッセイ、抗酸化能アッセイ、酵素ベースアッセイ、活性酸素種ベースアッセイに細分化されます。
• 技術別では、酵素結合免疫吸着アッセイ（ELISA）、フローサイトメトリー、クロマトグラフィー、顕微鏡、その他に二分されます。
• 疾患タイプ別では、市場は心血管疾患、慢性閉塞性肺疾患（COPD）、がん、呼吸器疾患、糖尿病、その他（神経変性疾患）に二分されます。
• エンドユーザー別では、市場は製薬・バイオテクノロジー産業、学術研究機関、臨床研究機関に細分化されます。

製薬・バイオテクノロジー産業が最大セグメントとなる見通し

エンドユーザー別では、酸化ストレスアッセイの世界市場は製薬・バイオテクノロジー産業、学術研究機関、臨床研究機関に細分化されます。このうち、製薬・バイオテクノロジー産業のサブセグメントが市場で最大のシェアを占めると予想されます。同分野の成長を支える主な要因としては、減税、薬価の低下、米国、中国、インドなどの地域の経済成長により製薬・バイオテクノロジー産業が成長を遂げており、研究開発への投資が増加していることが挙げられます。National Center for Biotechnology Informationによると、2021年3月に米国で減税と薬価引き下げが実施されたこと、中国とインドで国内総生産が6.0%以上の成長を遂げたこと、人口の高齢化と座りがちなライフスタイルが慢性疾患の増加につながったこと、研究開発におけるデータサービスが産業化され、臨床試験データを試験シミュレーションに利用できるようになったこと、米国で新薬の規制障壁が低下したこと、都市部の汚染レベルが高く喘息などの発症率が高まったことなどが、ヘルスケア市場の成長に寄与しています。

がんサブセグメントが大きな市場シェアを占める

酸化ストレスアッセイ市場は、がん罹患率の上昇と革新的な診断ソリューションへの需要によって成長を遂げています。アッセイプラットフォーム、スクリーニング手法、データ分析の進歩により、感度と特異性が向上しています。米国がん協会によると、2022年に米国で新たにがんと診断される症例は約190万件、がんによる死亡者数は推定60万9,360人と予測されています。

地域別展望

酸化ストレスアッセイの世界市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州）、アジア太平洋（インド、中国、日本、韓国、その他アジア太平洋）、世界のその他の地域（中東・アフリカ、ラテンアメリカ）を含む地域別に区分されています。

アジア太平洋におけるヘルスケア・インフラへの投資

特にインドなどの新興諸国では、診断サービスの強化や市場拡大のため、ヘルスケア・インフラの整備に重点を置く傾向が強まっており、医療費の増加やPMABHIM事業によってその重要性が浮き彫りになっています。2024年2月のHealthcareradius.inによると、保健医療費の総支出は大幅に増加しており、2023～24年の95億米ドルから2024～25年には109億米ドルに増加しています。さらに、プラダン・マントリ・アユシュマン・バラット保健基盤ミッション（PMABHIM）への配分も大幅に増加し、2023～24年の25億米ドルから2024～25年には497億米ドルに増加しました。

北米が主要市場シェアを占める

米国の酸化ストレスアッセイ市場は、米国における研究開発投資、国際共同研究、戦略的パートナーシップ、技術革新によって拡大しています。この市場は世界のヘルスケアニーズと成長に影響を与えています。国立科学技術統計センター（.gov）によると、2022年4月、米国の研究・実験開発実績は最近の動向で著しい成長を遂げ、2019年には総額6,670億米ドル、2020年には推定7,080億米ドルに達しました。この成長はすべてのセクターで見られ、特にビジネス・セクターで顕著です。さらに、研究開発投資の指標である米国の国家研究開発原単位は着実な伸びを示しており、2020年には3.39%に達します。

世界の酸化ストレスアッセイ市場に参入している主要企業には、Abcam Ltd.、Cell Biolabs, Inc.Merck KGaA、Promega Corp.、Thermo Fisher Scientific Inc.などが挙げられます。市場競争力を維持するため、提携、合併、買収などの戦略を適用して事業拡大や製品開拓に注力する企業が増えています。例えば、2022年2月、Invitae社は、業界をリードするAnchored Multiplex PCR化学体外診断（IVD）製品の一部であるFusionPlex DxとLiquidPlex Dxを欧州で発売しました。Invitaeは、がんとの闘いにおけるプレシジョン・オンコロジーに不可欠な高品質のイノベーションを提供しています。

目次

第1章 レポート概要

• 業界の現状分析と成長可能性の展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主要業界動向
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Abcam Ltd.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Merck KGaA
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Promega Corp.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 酸化ストレスアッセイの世界市場：製品別
  • 機器
  • 消耗品
  • サービス
• 酸化ストレスアッセイの世界市場：検査タイプ別
  • 間接アッセイ
  • 抗酸化能アッセイ
  • 酵素ベースアッセイ
  • 活性酸素種ベースのアッセイ
• 酸化ストレスアッセイの世界市場：技術別
  • 酵素結合免疫吸着アッセイ（ELISA）
  • フローサイトメトリー
  • クロマトグラフィー
  • 顕微鏡
  • その他（核磁気共鳴（NMR）分光法、分光光度法）
• 酸化ストレスアッセイの世界市場：疾患タイプ別
  • 心血管疾患
  • 慢性閉塞性肺疾患（COPD）
  • がん
  • 呼吸器疾患
  • 糖尿病
  • その他（炎症性疾患、神経疾患）
• 酸化ストレスアッセイの世界市場：エンドユーザー別
  • 製薬・バイオテクノロジー産業
  • 学術研究機関
  • 臨床研究機関

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 企業プロファイル

• AMSBIO
• Arbor Assays, Inc.
• Cayman Chemical Co.
• Cell Biolabs, Inc.
• Enzo Biochem, Inc.
• Enzo Life Sciences, Inc.
• F. Hoffmann-La Roche Ltd.
• Antibodies Inc.
• OXFORD BIOMEDICAL RESEARCH
• QIAGEN
• Sekisui Diagnostics, LLC.
• StressMarq Biosciences Inc.
• Thermo Fisher Scientific Inc.
• KAMIYA BIOMEDICAL CO.

LIST OF TABLES

• 1. Global Oxidative Stress Assay Market Research And Analysis By Product, 2023-2031 ($ Million)
• 2. Global Instruments Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 3. Global Consumables Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 4. Global Services Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 5. Global Oxidative Stress Assay Market Research And Analysis By Test Type, 2023-2031 ($ Million)
• 6. Global Indirect Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 7. Global Antioxidant Capacity Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 8. Global Enzyme Based Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 9. Global Reactive Oxygen Species Based Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 10. Global Oxidative Stress Assay Market Research And Analysis By Technology, 2023-2031 ($ Million)
• 11. Global Oxidative Stress Assay By Enzyme-Linked Immunosorbent Market Research And Analysis By Region, 2023-2031 ($ Million)
• 12. Global Oxidative Stress Assay By Flow Cytometry Market Research And Analysis By Region, 2023-2031 ($ Million)
• 13. Global Oxidative Stress Assay By Chromatography Market Research And Analysis By Region, 2023-2031 ($ Million)
• 14. Global Oxidative Stress Assay By Microscopy Market Research And Analysis By Region, 2023-2031 ($ Million)
• 15. Global Oxidative Stress Assay By Other Technology Market Research And Analysis By Region, 2023-2031 ($ Million)
• 16. Global Oxidative Stress Assay Market Research And Analysis By Disease Type, 2023-2031 ($ Million)
• 17. Global Cardiovascular Disease Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 18. Global Chronic Obstructive Pulmonary Disease Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 19. Global Cancer Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 20. Global Respiratory Diseases Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 21. Global Diabetes Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 22. Global Other Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 23. Global Oxidative Stress Assay Market Research And Analysis By End User, 2023-2031 ($ Million)
• 24. Global Oxidative Stress Assay In Pharmaceutical And Biotechnology Industries Market Research And Analysis By Region, 2023-2031 ($ Million)
• 25. Global Oxidative Stress Assay In Academic Research Institutes Market Research And Analysis By Region, 2023-2031 ($ Million)
• 26. Global Oxidative Stress Assay In Clinical Research Organizations Market Research And Analysis By Region, 2023-2031 ($ Million)
• 27. Global Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 28. North American Oxidative Stress Assay Market Research And Analysis By Country, 2023-2031 ($ Million)
• 29. North American Oxidative Stress Assay Market Research And Analysis By Product, 2023-2031 ($ Million)
• 30. North American Oxidative Stress Assay Market Research And Analysis By Test Type, 2023-2031 ($ Million)
• 31. North American Oxidative Stress Assay Market Research And Analysis By Technology, 2023-2031 ($ Million)
• 32. North American Oxidative Stress Assay Market Research And Analysis By Disease Type, 2023-2031 ($ Million)
• 33. North American Oxidative Stress Assay Market Research And Analysis By End User, 2023-2031 ($ Million)
• 34. European Oxidative Stress Assay Market Research And Analysis By Country, 2023-2031 ($ Million)
• 35. European Oxidative Stress Assay Market Research And Analysis By Product, 2023-2031 ($ Million)
• 36. European Oxidative Stress Assay Market Research And Analysis By Test Type, 2023-2031 ($ Million)
• 37. European Oxidative Stress Assay Market Research And Analysis By Technology, 2023-2031 ($ Million)
• 38. European Oxidative Stress Assay Market Research And Analysis By Disease Type, 2023-2031 ($ Million)
• 39. European Oxidative Stress Assay Market Research And Analysis By End User, 2023-2031 ($ Million)
• 40. Asia-Pacific Oxidative Stress Assay Market Research And Analysis By Country, 2023-2031 ($ Million)
• 41. Asia-Pacific Oxidative Stress Assay Market Research And Analysis By Product, 2023-2031 ($ Million)
• 42. Asia-Pacific Oxidative Stress Assay Market Research And Analysis By Test Type, 2023-2031 ($ Million)
• 43. Asia-Pacific Oxidative Stress Assay Market Research And Analysis By Technology, 2023-2031 ($ Million)
• 44. Asia-Pacific Oxidative Stress Assay Market Research And Analysis By Disease Type, 2023-2031 ($ Million)
• 45. Asia-Pacific Oxidative Stress Assay Market Research And Analysis By End User, 2023-2031 ($ Million)
• 46. Rest Of The World Oxidative Stress Assay Market Research And Analysis By Region, 2023-2031 ($ Million)
• 47. Rest Of The World Oxidative Stress Assay Market Research And Analysis By Product, 2023-2031 ($ Million)
• 48. Rest Of The World Oxidative Stress Assay Market Research And Analysis By Test Type, 2023-2031 ($ Million)
• 49. Rest Of The World Oxidative Stress Assay Market Research And Analysis By Technology, 2023-2031 ($ Million)
• 50. Rest Of The World Oxidative Stress Assay Market Research And Analysis By Disease Type, 2023-2031 ($ Million)
• 51. Rest Of The World Oxidative Stress Assay Market Research And Analysis By End User, 2023-2031 ($ Million)

LIST OF FIGURES

• 1. Global Oxidative Stress Assay Market Share By Product, 2023 Vs 2031 (%)
• 2. Global Instruments Oxidative Stress Assay Market Share By Region, 2023 Vs 2031 (%)
• 3. Global Consumables Oxidative Stress Assay Market Share By Region, 2023 Vs 2031 (%)
• 4. Global Services Oxidative Stress Assay Market Share By Region, 2023 Vs 2031 (%)
• 5. Global Oxidative Stress Assay Market Share By Test Type, 2023 Vs 2031 (%)
• 6. Global Indirect Assays Oxidative Stress Assay Market Share By Region, 2023 Vs 2031 (%)
• 7. Global Antioxidant Capacity Oxidative Stress Assay Market Share By Region, 2023 Vs 2031 (%)
• 8. Global Enzyme-Based Oxidative Stress Assay Market Share By Region, 2023 Vs 2031 (%)
• 9. Global Reactive Oxygen Species-Based Oxidative Stress Assay Market Share By Region, 2023 Vs 2031 (%)
• 10. Global Oxidative Stress Assay Market Share By Technology, 2023 Vs 2031 (%)
• 11. Global Oxidative Stress Assay By Enzyme-Linked Immunosorbent Market Share By Region, 2023 Vs 2031 (%)
• 12. Global Oxidative Stress Assay By Flow Cytometry Market Share By Region, 2023 Vs 2031 (%)
• 13. Global Oxidative Stress Assay By Chromatography Market Share By Region, 2023 Vs 2031 (%)
• 14. Global Oxidative Stress Assay By Microscopy Market Share By Region, 2023 Vs 2031 (%)
• 15. Global Oxidative Stress Assay Other Technology Market Share By Region, 2023 Vs 2031 (%)
• 16. Global Oxidative Stress Assay Market Share By Disease Type, 2023 Vs 2031 (%)
• 17. Global Cardiovascular Disease Oxidative Stress Assay Market Share By Region, 2023 Vs 2031 (%)
• 18. Global Chronic Obstructive Pulmonary Disease Oxidative Stress Assay Market Share By Region, 2023 Vs 2031 (%)
• 19. Global Cancer Oxidative Stress Market Share By Region, 2023 Vs 2031 (%)
• 20. Global Respiratory Diseases Oxidative Stress Market Share By Region, 2023 Vs 2031 (%)
• 21. Global Diabetes Oxidative Stress Market Share By Region, 2023 Vs 2031 (%)
• 22. Global Others Oxidative Stress Market Share By Region, 2023 Vs 2031 (%)
• 23. Global Oxidative Stress Assay Market Share By End User, 2023 Vs 2031 (%)
• 24. Global Oxidative Stress Assay In Pharmaceutical And Biotechnology Industries Market Share By Region, 2023 Vs 2031 (%)
• 25. Global Oxidative Stress Assay In Academic Research Institutes Market Share By Region, 2023 Vs 2031 (%)
• 26. Global Oxidative Stress Assay In Clinical Research Organizations Market Share By Region, 2023 Vs 2031 (%)
• 27. Global Oxidative Stress Assay Market Share By Region, 2023 Vs 2031 (%)
• 28. US Oxidative Stress Assay Market Size, 2023-2031 ($ Million)
• 29. Canada Oxidative Stress Assay Market Size, 2023-2031 ($ Million)
• 30. UK Oxidative Stress Assay Market Size, 2023-2031 ($ Million)
• 31. France Oxidative Stress Assay Market Size, 2023-2031 ($ Million)
• 32. Germany Oxidative Stress Assay Market Size, 2023-2031 ($ Million)
• 33. Italy Oxidative Stress Assay Market Size, 2023-2031 ($ Million)
• 34. Spain Oxidative Stress Assay Market Size, 2023-2031 ($ Million)
• 35. Rest Of Europe Oxidative Stress Assay Market Size, 2023-2031 ($ Million)
• 36. India Oxidative Stress Assay Market Size, 2023-2031 ($ Million)
• 37. China Oxidative Stress Assay Market Size, 2023-2031 ($ Million)
• 38. Japan Oxidative Stress Assay Market Size, 2023-2031 ($ Million)
• 39. South Korea Oxidative Stress Assay Market Size, 2023-2031 ($ Million)
• 40. Rest Of Asia-Pacific Oxidative Stress Assay Market Size, 2023-2031 ($ Million)
• 41. Latin America Oxidative Stress Assay Market Size, 2023-2031 ($ Million)
• 42. Middle East And Africa Oxidative Stress Assay Market Size, 2023-2031 ($ Million)

Global Oxidative Stress Assay Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables, and Services), by Test Type (Indirect Assays, Antioxidant Capacity Assays, Enzyme Assays, and Reactive Oxygen Species Assays) by Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Flow Cytometry, Chromatography, Microscopy, and Others) by Disease Type (Cardiovascular Disease, Chronic Obstructive Pulmonary Disease (COPD), Cancer, Respiratory Diseases, Diabetes, and Other) and by End User (Pharmaceutical and Biotechnology Industries, Academic Research institutes, and Clinical Research Organizations) Forecast Period (2024-2031)

The global oxidative stress assay market is anticipated to grow at a CAGR of 8.3% during the forecast period (2024-2031). The global oxidative stress assay market is influenced by various factors, including the increasing prevalence of chronic diseases, the aging population, environmental factors, and the shift toward personalized medicine. Chronic diseases, such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders, are more susceptible to oxidative stress due to reduced antioxidant defense mechanisms. The aging population is additionally more susceptible to oxidative stress due to increased exposure to pollutants and toxins. The shift towards personalized medicine has fueled the demand for biomarker-based assays, enabling healthcare providers to tailor treatment strategies based on individual patient characteristics. Technological advancements have improved the sensitivity, specificity, and accuracy of oxidative stress measurements. Regulatory support from agencies like the FDA and EMA encourages adoption in healthcare settings. Awareness campaigns and collaborations between academic institutions, research organizations, and biotechnology companies further drive market growth.

Market Dynamics

Increased Susceptibility to Oxidative Stress

The aging leads to decreased antioxidant defenses, increasing oxidative stress-related conditions. As the aging population grows, the demand for oxidative stress assays increases for early detection and monitoring. According to the Centers for Disease Control and Prevention (.gov), in September 2022, the aging population in the US has reached unprecedented levels, with $54.1 million adults aged 65 or older in 2019, accounting for 16.0% of the population. By 2040, it is projected that this number will increase to $80.8 million, and by 2060, it will reach $94.7 million, comprising almost 25.0% of the total population. With age, the risk of chronic diseases such as dementia, heart disease, type 2 diabetes, arthritis, and cancer also increases, leading to significant healthcare costs and societal implications.

Rising Public Health Initiatives and Government Policies

Governments and international organizations are investing in public health initiatives to address chronic diseases and improve healthcare infrastructure. Integrating oxidative stress assays into national health programs supports evidence-based policymaking and stimulates market growth. According to the World Health Organization (WHO), in December 2023, global health spending reached a new high of $9.8 trillion, accounting for 10.3% of GDP. However, the distribution of spending remained unequal, with public spending increasing globally, except in low-income countries where government spending decreased. Low-income countries accounted for only 0.24% of global health expenditure.

Market Segmentation

Our in-depth analysis of the global oxidative stress assay market includes the following segments by product, test type, technology, disease type, and end-user:

• Based on product, the market is sub-segmented into instruments, consumables, and services.
• based on test type, the market is sub-segmented into indirect assays, antioxidant capacity assays, enzyme-based assays, and reactive oxygen species-based assays.
• Based on technology, the market is bifurcated into Enzyme-Linked Immunosorbent Assay (ELISA), flow cytometry, chromatography, microscopy, and others.
• Based on disease type, the market is bifurcated into cardiovascular disease, Chronic Obstructive Pulmonary Disease (COPD), cancer, respiratory diseases, diabetes, and other (neurodegenerative diseases).
• Based on end-users, the market is sub-segmented into pharmaceutical and biotechnology industries, academic research institutes, and clinical research organizations.

Pharmaceutical and Biotechnology Industries is Projected to Emerge as the Largest Segment

Based on the business model, the global oxidative stress assay market is sub-segmented into pharmaceutical and biotechnology industries, academic research institutes, and clinical research organizations. Among these, the advertising-supported model sub-segment is expected to hold the largest share of the market. The primary factor supporting the segment's growth includes the pharmaceutical and biotechnology industries are experiencing growth owing to reduced taxes, lower drug prices, and economic growth in regions such as the US, China, and India, leading to increased investment in R&D. According to the National Center for Biotechnology Information, in March 2021, it reduced taxes and lowered drug prices in the US, a gross domestic product growth greater than 6.0% in China and India, widespread population aging and sedentary lifestyles leading to increased chronic diseases, industrialized data services in R&D enabling the use of clinical trial data in trial simulations, lowered regulatory barriers for new drugs in the US, and high urban pollution levels increasing the incidence of conditions such as asthma, have contributed to the growth of the healthcare market.

Cancer Sub-segment to Hold a Considerable Market Share

The oxidative stress assay market is experiencing growth owing to the rise in cancer incidence and demand for innovative diagnostic solutions. Advancements in assay platforms, screening methodologies, and data analytics enhance their sensitivity and specificity. According to the American Cancer Society, in 2022, it is projected approximately $1.9 million new cases of cancer diagnosed and an estimated 609,360 fatalities caused by cancer in the US.

Regional Outlook

The global oxidative stress assay market is segmented based on geography including North America (the US, and Canada), Europe (the UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Investment in Healthcare Infrastructure in the Asia-Pacific Region

A growing emphasis on improving healthcare infrastructure, especially in developing countries such as India for enhanced diagnostic services and market expansion, is highlighted by the rise in health expenditure and PMABHIM operations. According to the Healthcareradius.in, February 2024, the total expenditure on health has seen a significant increase, rising from $9.5 billion in 2023-24 to $10.9 billion in 2024-25. In addition, the allocation for the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PMABHIM) has also experienced a substantial boost, going up from $2.5 in 2023-24 to $49.7 in 2024-25.

North America Holds Major Market Share

The US oxidative stress assay market is expanding owing to the R&D investment in the US, international collaborations, strategic partnerships, and technological innovation. This market is influencing global healthcare needs and growth. According to the National Center for Science and Engineering Statistics (.gov), in April 2022, the US research and experimental development performance experienced significant growth in recent years, with the total reaching $667.0 billion in 2019 and an estimated $708.0 billion in 2020. This growth was observed across all sectors, particularly in the business sector. Additionally, the US national R&D intensity, a measure of R&D investment, has shown a steady increase, reaching 3.39% in 2020.

The major companies serving the global oxidative stress assay market include Abcam Ltd., Cell Biolabs, Inc. Merck KGaA, Promega Corp., and Thermo Fisher Scientific Inc. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in February 2022, Invitae launched the availability of FusionPlex Dx and LiquidPlex Dx in Europe, part of its industry-leading Anchored Multiplex PCR chemistry in-vitro diagnostic (IVD) products. Invitae is delivering essential high-quality innovation for precision oncology in the fight against cancer.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Industry Trends
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Abcam Ltd.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Merck KGaA
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Promega Corp.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Oxidative Stress Assay Market by Product
  • 4.1.1. Instruments
  • 4.1.2. Consumables
  • 4.1.3. Services
• 4.2. Global Oxidative Stress Assay Market by Test Type
  • 4.2.1. Indirect assays
  • 4.2.2. Antioxidant capacity assays
  • 4.2.3. Enzyme-based assays
  • 4.2.4. Reactive Oxygen species based assays
• 4.3. Global Oxidative Stress Assay Market by Technology
  • 4.3.1. Enzyme-linked Immunosorbent Assay (ELISA)
  • 4.3.2. Flow Cytometry
  • 4.3.3. Chromatography
  • 4.3.4. Microscopy
  • 4.3.5. Others (Nuclear Magnetic Resonance (NMR) Spectroscopy, and Spectrophotometry)
• 4.4. Global Oxidative Stress Assay Market by Disease Type
  • 4.4.1. Cardiovascular disease
  • 4.4.2. Chronic Obstructive pulmonary disease (COPD)
  • 4.4.3. Cancer
  • 4.4.4. Respiratory Diseases
  • 4.4.5. Diabetes
  • 4.4.6. Others (Inflammatory Diseases, Neurological Disorders)
• 4.5. Global Oxidative Stress Assay Market by End-user
  • 4.5.1. Pharmaceutical and Biotechnology Industries
  • 4.5.2. Academic Research Institutes
  • 4.5.3. Clinical Research Organizations

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World
  • 5.4.1. Latin America
  • 5.4.2. Middle East & Africa

6. Company Profiles

• 6.1. AMSBIO
• 6.2. Arbor Assays, Inc.
• 6.3. Cayman Chemical Co.
• 6.4. Cell Biolabs, Inc.
• 6.5. Enzo Biochem, Inc.
• 6.6. Enzo Life Sciences, Inc.
• 6.7. F. Hoffmann-La Roche Ltd.
• 6.8. Antibodies Inc.
• 6.9. OXFORD BIOMEDICAL RESEARCH
• 6.10. QIAGEN
• 6.11. Sekisui Diagnostics, LLC.
• 6.12. StressMarq Biosciences Inc.
• 6.13. Thermo Fisher Scientific Inc.
• 6.14. KAMIYA BIOMEDICAL CO.